UnknownNot Applicable

Cost-effectiveness of EGDT Using FloTrac/EV1000

Thailand60 participantsStarted 2023-04-01

Plain-language summary

Coronary artery bypass graft (CABG) with cardiopulmonary bypass (CPB) is a high-risk surgery with significant morbidity that results in a prolonged stay in the intensive care unit (ICU) at an increased cost. Early goal-directed therapy (EGDT) using the FloTrac/EV1000 platform improved outcomes in these patients with shorter ICU stay but with extra cost for a FloTrac transducer. The objective of this study is to assess the cost-effectiveness of implementing the FloTrac/EV1000 in these patients.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients who underwent CABG with CPB. Exclusion Criteria: * Patients who required an intra-aortic balloon pump or extracorporeal membrane oxygenator.

What they're measuring

ICU stay

Timeframe: 1 month

Trial details

NCT IDNCT05826795

SponsorKhon Kaen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-05-01

Contact for this trial

Thepakorn Sathitkarnmanee, MD

66-81-9547622 thepakorns@gmail.com

View on ClinicalTrials.gov More Coronary Artery Disease trials